多巴胺与免疫反应调节的研究进展

被引:11
作者
黄洁 [1 ,2 ]
徐格致 [1 ]
机构
[1] 复旦大学附属眼耳鼻喉科医院眼科
[2] 复旦大学上海医学院
关键词
多巴胺; 多巴胺受体; 免疫; 白细胞; 炎症;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100108 [医学免疫学];
摘要
神经递质多巴胺(dopamine,DA)是联接神经和免疫的重要分子。白细胞能合成和转运DA,几乎所有的免疫细胞亚群都表达DA受体,DA与其受体结合,通过自分泌/旁分泌方式调节免疫细胞的活化、增殖和细胞因子分泌。在中枢神经系统和外周组织,DA主要通过D1和D2受体抑制或加强免疫效应细胞的功能。中枢神经系统退行性疾病表现出免疫功能失调,可能与免疫细胞上DA受体表达水平以及信号传导通路的变化相关。因此,选择性针对免疫细胞的DA受体激动剂或拮抗剂在治疗DA介导的免疫失调性疾病中可能发挥重要作用。本文就DA受体在免疫细胞上的表达、DA作为免疫调节分子的作用以及在免疫功能障碍相关疾病中的研究进展作一综述。
引用
收藏
页码:722 / 726+734 +734
页数:6
相关论文
共 25 条
[1]
多巴胺D2受体调控睡眠-觉醒研究进展 [J].
许奇 ;
曲卫敏 ;
黄志力 .
中国临床药理学与治疗学, 2010, 15 (04) :361-366
[2]
Immunomodulatory Effects Mediated by Dopamine[J] Rodrigo Arreola;Samantha Alvarez-Herrera;Gilberto Pérez-Sánchez;Enrique Becerril-Villanueva;Carlos Cruz-Fuentes;Enrique Octavio Flores-Gutierrez;María Eugenia Garcés-Alvarez;Dora Luz de la Cruz-Aguilera;Emilio Medina-Rivero;Gabriela Hurtado-Alvarado;Saray Quintero-Fabián;Lenin Pavón;Peirong Jiao Journal of Immunology Research 2016,
[3]
Reduction of rat brain CD 8<sup>+</sup> T‐cells by levodopa/benserazide treatment after experimental stroke[J] Enida Kuric;Karsten Ruscher Eur J Neurosci 2014,
[4]
Levodopa Treatment Improves Functional Recovery After Experimental Stroke[J] Karsten Ruscher;Enida Kuric;Tadeusz Wieloch Stroke 2012,
[5]
Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis[J] Kazuhisa Nakano;Takehiro Higashi;Kumiko Hashimoto;Rie Takagi;Yoshiya Tanaka;Sho Matsushita Biochemical and Biophysical Research Communications 2008,
[6]
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.[J] Cosentino Marco;Fietta Anna Maria;Ferrari Marco;Rasini Emanuela;Bombelli Raffaella;Carcano Elena;Saporiti Federica;Meloni Federica;Marino Franca;Lecchini Sergio Blood 2007,
[7]
Cutting Edge: Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation.[J] Sarkar Chandrani;Das Shamik;Chakroborty Debanjan;Chowdhury Uttio Roy;Basu Biswarup;Dasgupta Partha Sarathi;Basu Sujit Journal of immunology (Baltimore; Md. : 1950) 2006,
[8]
Effect of GLC756; a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist; on TNF-alpha release in vitro from activated rat mast cells[J] Ulrich Wilhelm Laengle;Rudolf Markstein;Dominique Pralet;Wolfgang Seewald;Danielle Roman Experimental Eye Research 2006,
[9]
GLC756 decreases TNF-α via an alpha2 and beta2 adrenoceptor related mechanism[J] Ulrich W. Laengle;Anne U. Trendelenburg;Rudolf Markstein;Vicente Nogues;Anne Provencher-Bollinger;Danielle Roman Experimental Eye Research 2006,
[10]
Dopaminergic effects on encoding of a motor memory in chronic stroke[J] A Floel;F Hummel;C Breitenstein;S Knecht;L G. Cohen Neurology 2005,